Tiptree (TIPT) risk factors

85 risks, 23 new, 9 dropped, 14 reworded since the prior year. Tiptree faces extensive new risks and uncertainty surrounding the pending sale of Fortegra for $1.65 billion in cash.

71 risks. Tiptree faces significant concentration and execution risks centered around its primary insurance subsidiary Fortegra, active acquisitions, and investment liquidity. Operations are heavily exposed to regulatory capital requirements, claims reserve accuracy, and competitive financial markets. Third-party vendor dependencies and technological vulnerabilities also dominate the risk profile.